Innovative Health Initiative Joint Undertaking (IHI JU)

Funds one consortium to build a scannable digital-label standard that replaces cluttered printed labelling on medical devices and diagnostics.

Funds one project to build frameworks, guidance and recommendations that protect IP, trade secrets and regulatory data when health data is reused under the EHDS.

Funds one project to map, replace, reduce and safely dispose of PFAS chemicals used in medicines, vaccines, devices and diagnostics.

Funds one large data platform that identifies shared biological markers for reward, motivation and impulsivity symptoms across Alzheimer's, depression, obesity and related disorders.

Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Funds one project to build the infrastructure, training and digital tools needed to run same-day orthopaedic and cardiology surgical centres in Europe.

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Funds public-private research that connects fragmented health R&I efforts into shared tools, data, platforms and manufacturing processes.

Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.

Funds public-private research on interoperable health data and AI analytics that speed up diagnosis, treatment and personalised care.

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.

Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.

Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.